Skip to content

TransMedics Group, Inc. TMDX Interest Income And Other Income Expense

Interest Income And Other Income Expense at other companies

Beam Therapeutics logo
Beam TherapeuticsBEAM
$9.87M0.0%
FTI Consulting logo
FTI ConsultingFCN
$1.07M-62.2%
Payoneer Global Inc. logo
Payoneer Global Inc.PAYO
-$812K+47.6%
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$13.5M+696%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$9M-18.2%
Noble Corporation logo
Noble CorporationNE
$8.2M+346%

Other financials

Income statement

See full
Revenue$173.9M+21.2%
Gross profit$101.2M+14.7%
Operating income$13.3M-51.5%
Net income$7.3M-71.5%
EPS (diluted)$0.20-71.4%

Balance sheet

See full
Cash & equivalents$461.7M+48.9%
Total debt$409.9M+505%
Total equity$494.0M+85.5%
Total assets$1.4B+71.3%

Cash flow

See full
Operating cash flow$24.5M+959%
CapEx$36.7M+35.6%
Free cash flow-$12.1M+59.4%

Valuation

See full
Market cap$2.55B+50.6%
Enterprise value$2.5B+66.0%
P/E14.8×-19.8×
P/S+0.5×

Profitability

See full
Gross margin59.1%-0.4pp
Operating margin14.9%+4.1pp
Net margin27%+17.0pp
FCF margin23.8%

Returns & leverage

See full
Return on equity45.2%+22.2pp
Debt / equity0.8×+0.6×
Current ratio6.7×-2.4×

Where this comes from

Reported directly by TransMedics Group, Inc. in its filing.

Tagged under the XBRL concept tmdx:InterestIncomeAndOtherIncomeExpense.

The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransMedics Group, Inc.'s interest income and other income expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TransMedics Group, Inc.'s interest income and other income expense?
TransMedics Group, Inc. (TMDX) reported interest income and other income expense of $2.36M in Q1 2026.
How has TransMedics Group, Inc.'s interest income and other income expense changed year-over-year?
TransMedics Group, Inc.'s interest income and other income expense decreased by 12.5% year-over-year, from $2.69M to $2.36M.
What is the long-term trend for TransMedics Group, Inc.'s interest income and other income expense?
Over 3 years (2022 to 2025), TransMedics Group, Inc.'s interest income and other income expense has grown at a 133.3% compound annual growth rate (CAGR), from -$1M to $12.72M.
What does interest income and other income expense mean?
This metric captures the net financial impact of non-operating activities, primarily consisting of interest earned on cash balances and other miscellaneous income or expense items. It provides insight into the company's ability to generate returns on its liquid assets outside of its core medical technology operations. Monitoring this helps analysts distinguish between operational performance and gains or losses derived from treasury management and peripheral business activities.